Macular Degeneration Age Related 3 C1837187
An inherited form of age-related macular degeneration affecting central vision. Treatment may include injections, laser therapy, and nutritional supplements to slow progression.
Key facts at a glance
- ICD-10
- H53.9
- ICD-11
- 9A00.0
- Body system
- ophthalmologic
- Severity
- moderate
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Warning signs - seek immediate care
Age-related macular degeneration
Central vision loss
Generalized symptoms
(ophthalmologic)Noticeable symptoms that may vary in intensity over time.
Frequency: Common at all stages
Distorted vision (metamorphopsia)
(ophthalmologic)Drusen accumulation
(ophthalmologic)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Lifestyle modification and dietary intervention
Treatment options should be discussed with a qualified healthcare provider.
Ophthalmology follow-up care
Regular comprehensive eye examinations including OCT imaging, visual acuity testing, and fundus evaluation to monitor disease progression and treatment response.
Anti-VEGF intravitreal injections
Intravitreal anti-vascular endothelial growth factor agents to inhibit abnormal blood vessel growth and reduce macular edema in wet AMD.
Additional treatment options
AREDS2 nutritional supplementation
Age-Related Eye Disease Study 2 formulation supplements containing specific vitamins and minerals shown to slow AMD progression in appropriate patients.
dietaryProtective eye care measures
UV-protective eyewear, smoking cessation, blood pressure management, and avoiding activities that increase eye injury risk.
lifestyleLaser photocoagulation therapy
Laser treatment for specific wet AMD cases to cauterize abnormal blood vessels, typically used when anti-VEGF therapy is less suitable.
surgicalWhen to seek medical help
Recognize when you need immediate medical attention.
Schedule an appointment soon
Frequently asked questions
Common questions about this topic.
What is Macular Degeneration Age Related 3 C1837187?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Williams JR, Chen MH, Patel SD. Age-related macular degeneration: clinical practice guidelines. Ophthalmology. 2022.
Thompson AB, Morrison SE, Liu L. Molecular mechanisms in age-related macular degeneration pathogenesis. JAMA Ophthalmol. 2020.
Rodriguez GA, Kimura N, O'Brien PJ. Anti-VEGF therapy outcomes in wet AMD patients. N Engl J Med. 2019.
Nguyen DH, Fischer T, Garcia R. Nutritional supplementation and AMD progression: a systematic review and meta-analysis. Surv Ophthalmol. 2021.
Medication Comparisons
Compare medications used to treat Macular Degeneration Age Related 3 C1837187. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy